Microbot Medical Inc.
MBOT
$2.41
$0.114.78%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 226.87% | 116.94% | 47.35% | 28.56% | 45.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.64% | 17.00% | 48.27% | 26.72% | 65.86% |
| Operating Income | -20.64% | -17.00% | -48.27% | -26.72% | -65.86% |
| Income Before Tax | -2.12% | -11.26% | -41.99% | -9.70% | -7.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.12% | -11.26% | -41.99% | -9.70% | -7.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.12% | -11.26% | -41.99% | -9.70% | -7.55% |
| EBIT | -20.64% | -17.00% | -48.27% | -26.72% | -65.86% |
| EBITDA | -21.27% | -17.52% | -48.62% | -27.59% | -67.44% |
| EPS Basic | 73.90% | 61.89% | 42.23% | 50.39% | 25.94% |
| Normalized Basic EPS | 73.88% | 61.89% | 42.20% | 44.40% | -14.48% |
| EPS Diluted | 73.90% | 61.89% | 42.23% | 50.39% | 25.94% |
| Normalized Diluted EPS | 73.88% | 61.89% | 42.20% | 44.40% | -14.48% |
| Average Basic Shares Outstanding | 291.55% | 191.99% | 145.77% | 121.16% | 45.18% |
| Average Diluted Shares Outstanding | 291.55% | 191.99% | 145.77% | 121.16% | 45.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |